Impact of GLP-1 Agonists on Male Reproductive Health-A Narrative Review
Neopterin release and tryptophan degradation in patients with uveitis
Both SubQ and IM routes appear in clinic and community protocols, while IV administration is also common in supervised settings
As an amylin receptor agonist, Cagrilintide acts through a fundamentally different pathway compared to incretin-based peptides like Retatrutide
In contrast to injections, topical serums are cost-effective, practical, and have a good safety profile, in addition to providing potential benefits for hair and skin support
Cycle Guidelines Common Cagrilintide + Retatrutide Cycle Approaches Approach Full staggered titration Duration 24-week ramp + open-ended maintenance Off Period Community: 16-24 weeks on, 4-8 weeks off Best For Primary weight-loss strategy with full pathway coverage Approach Reta-first, cag add-on Duration Stabilize reta at 8-12 mg, then add cag for 12+ weeks Off Period Cag can be cycled on its own Best For Users already on retatrutide who want more satiety Approach Short-cycle test Duration 8-12 weeks at sub-maximal doses Off Period 4 weeks off Best For Initial tolerability check Taper retatrutide at the end of a cycle rather than stopping suddenly